V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010053 | 270005904 | 1.69 | 102 | Palliative (P) | 2018-01-07 | 2018-01-22 | ECHELON-1 TRIAL | N | null | 270022677 | CVP R |
| 270010054 | 270005905 | 1.62 | 80.9 | Not known (9) | 2015-05-16 | 2015-05-24 | Dacarbazine | 02 | N | 270022685 | BRENTUXIMAB |
| 270010055 | 270005905 | 1.79 | 102 | Adjuvant (A) | null | 2017-08-18 | CVP | null | null | 270022685 | CVP R |
| 270010056 | 270005906 | 1.55 | 70.6 | Curative (C) | 2015-04-29 | 2015-05-24 | LOPP | 02 | N | 270022695 | CVP R |
| 270010057 | 270005906 | 1.7 | null | Not known (9) | 2014-03-13 | 2014-03-14 | Bendamustine+Rituximab (1st Course) | N | N | 270022695 | CHLORAMBUCIL |
| 270010058 | 270005907 | 1.74 | 96 | Curative (C) | 2018-03-29 | 2018-04-07 | Brentuximab Vedotin | 02 | N | 270022706 | BENDAMUSTINE + RITUXIMAB |
| 270010059 | 270005908 | 1.79 | 73.9 | Not known (9) | 2015-09-30 | 2015-10-27 | Vinblastine | N | N | 270022723 | NOT MATCHED |
| 270010060 | 270005909 | null | 85 | Curative (C) | 2016-10-12 | 2016-11-03 | Rituximab | N | N | 270022732 | CYCLOPHOSPHAMIDE |
| 270010061 | 270005910 | 1.6 | null | null | null | 2013-06-03 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270022747 | BENDAMUSTINE + RITUXIMAB |
| 270010062 | 270005910 | 1.62 | 69.2 | Adjuvant (A) | 2014-11-02 | 2014-11-04 | ESHAP R | N | N | 270022747 | FEC |
| 270010063 | 270005911 | 1.73 | 78 | Curative (C) | 2016-05-20 | 2016-05-20 | CVP | Y | N | 270022772 | CVD |
| 270010064 | 270012919 | 1.76 | 88.8 | Curative (C) | 2015-07-30 | 2015-08-08 | CVP | N | N | 270022778 | NOT MATCHED |
| 270010065 | 270005912 | 1.7 | 65.6 | Curative (C) | 2013-05-21 | 2013-06-17 | NHL 2003 Gp B COP | Y | null | 270022787 | ABVD R |
| 270010066 | 270005912 | 1.78 | 47.8 | Curative (C) | 2016-09-24 | 2016-10-16 | null | N | N | 270022787 | GEMCITABINE + VINORELBINE |
| 270010067 | 270016074 | null | null | Curative (C) | null | 2014-09-06 | Vinblastine | null | null | 270022794 | CHOP |
| 270010068 | 270005913 | 1.47 | 47 | Palliative (P) | null | 2013-09-17 | ECHELON 1 TRIAL | N | N | 270022796 | NOT MATCHED |
| 270010069 | 270005914 | 1.62 | 66.2 | Curative (C) | 2015-07-28 | 2015-07-29 | CVP R | N | N | 270022798 | MITOMYCIN INTRAVESICULAR |
| 270010070 | 270005915 | null | null | Palliative (P) | 2014-10-02 | 2014-10-05 | GEM-P | null | null | 270022801 | CVP R |
| 270010071 | 270005915 | 1.83 | null | Adjuvant (A) | 2017-08-07 | 2017-08-16 | Brentuximab | N | N | 270022801 | CVP R |
| 270010072 | 270005916 | 1.73 | 81.6 | Curative (C) | 2016-10-02 | 2016-10-09 | Rituximab | Y | N | 270022812 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 270010073 | 270005916 | 1.82 | 65.5 | Curative (C) | 2014-06-12 | 2014-06-23 | GDP | N | N | 270022812 | IBRUTINIB |
| 270010074 | 270005916 | 1.72 | 90.8 | Curative (C) | 2014-05-31 | 2014-06-18 | R ABVD | 02 | N | 270022812 | DHAP |
| 270010075 | 270005917 | 1.82 | 59.42 | T | null | 2014-06-01 | GEM-P | N | N | 270022820 | DHAP |
| 270010076 | 270005918 | null | 43 | null | 2017-02-04 | 2017-02-15 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 270022855 | CLADRIBINE |
| 270010077 | 270005919 | null | 58 | 1 | 2014-02-28 | 2014-03-02 | ESHAP | 2 | N | 270022858 | MYELOMA XI TRIAL |
| 270010078 | 270005920 | 1.53 | null | Curative (C) | 2017-08-21 | 2017-08-28 | Brentuximab | N | N | 270022864 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 270010079 | 270005921 | 1.83 | 99.7 | Adjuvant (A) | 2014-08-01 | 2014-08-23 | Cytarabine High Dose | N | N | 270022878 | LOPP |
| 270010080 | 270005922 | 1.77 | 74 | T | 2013-10-09 | 2013-10-11 | DHAP | N | N | 270022884 | ABVD R |
| 270010081 | 270005923 | 1.67 | 76 | Curative (C) | 2017-10-19 | 2017-11-10 | Vinblastine | N | Y | 270022895 | DHAP |
| 270010082 | 270005923 | null | 62.5 | Curative (C) | 2015-04-29 | 2015-05-07 | ABVD R | N | N | 270022895 | BENDAMUSTINE + RITUXIMAB |
| 270010083 | 270005924 | 1.6 | 66 | Curative (C) | 2016-02-04 | 2016-02-04 | CVP R | N | N | 270022919 | NOT MATCHED |
| 270010084 | 270012924 | 1.74 | 0 | Curative (C) | 2017-09-04 | 2017-09-20 | Brentuximab Vedotin | N | Y | 270022921 | DACARBAZINE |
| 270010085 | 270005925 | null | 75 | Curative (C) | 2013-04-10 | 2013-04-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270022930 | CVP R |
| 270010086 | 270012925 | null | 73 | Curative (C) | 2016-01-11 | 2016-01-12 | Chlorambucil | 2 | N | 270022932 | BRENTUXIMAB |
| 270010087 | 270012925 | null | 53.3 | null | 2017-02-01 | 2017-02-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270022932 | ECHELON-2 TRIAL |
| 270010088 | 270012925 | 1.65 | null | Disease modification (D) | 2013-09-23 | 2013-09-24 | CVP R | Y | N | 270022932 | CVP R |
| 270010089 | 270018902 | 1.75 | 70.4 | Disease modification (D) | 2017-09-12 | 2017-09-25 | CARBOPLATIN + FLUOROURACIL | N | N | 270022948 | CHLORAMBUCIL |
| 270010090 | 270005926 | 1.68 | 83.2 | Disease modification (D) | 2016-03-30 | 2016-04-09 | Chlorambucil | 02 | N | 270022951 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270010091 | 270005927 | 0 | 59.7 | Disease modification (D) | 2016-11-14 | 2016-11-15 | DHAP | 02 | N | 270022954 | VINBLASTINE |
| 270010092 | 270005927 | 1.78 | 119 | Palliative (P) | 2016-10-26 | 2016-10-31 | CVP R | 2 | N | 270022954 | ESHAP |
| 270010093 | 270005928 | 1.65 | 74.9 | Curative (C) | 2015-01-06 | 2015-01-06 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 270022967 | CVP R |
| 270010094 | 270005928 | 1.72 | 93 | Curative (C) | 2013-08-13 | 2013-08-15 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 270022967 | VINBLASTINE |
| 270010095 | 270005929 | 1.7 | 84.3 | Palliative (P) | null | 2017-06-18 | null | N | N | 270022977 | CVP R |
| 270010096 | 270005929 | 1.8 | 71 | Disease modification (D) | 2013-12-25 | 2013-12-27 | CVP R | N | N | 270022977 | LOPP |
| 270010097 | 270005930 | 1.65 | 90.9 | null | 2015-05-01 | 2015-05-24 | Rituximab | N | N | 270022984 | CVP R |
| 270010098 | 270005930 | null | 58.3 | Curative (C) | 2016-12-22 | 2017-01-14 | Carboplatin + Pemetrexed | null | null | 270022984 | ECHELON 1 TRIAL |
| 270010099 | 270016077 | 1.8 | 70.1 | Palliative (P) | 2014-10-25 | 2014-10-25 | DOXORUBICIN + GEMCITABINE + VINBLASTINE | N | N | 270023006 | NOT MATCHED |
| 270010100 | 270016077 | 1.6 | 70.6 | Palliative (P) | 2016-10-26 | 2016-10-28 | CISPLATIN + GEMCITABINE | N | N | 270023006 | CHOP |
| 270010101 | 270016077 | 1.66 | 85 | Curative (C) | 2015-06-22 | 2015-06-22 | COPP | 02 | N | 270023006 | ECHELON 1 TRIAL |
| 270010102 | 270005931 | null | 74 | Palliative (P) | 2013-10-02 | 2013-10-28 | ETOPOSIDE | N | N | 270023046 | BEAM + ALEMTUZUMAB |